Browse > Article
http://dx.doi.org/10.15204/jkobgy.2010.23.4.155

A Study on Oriental Medicine Diagnostic Application through Analysis of Heart Rate Variability in Polycystic Ovary Syndrome Females  

Lee, Mi-Joo (KangNam Kyung-Hee Oriental Hospital)
Hwang, Deok-Sang (KangNam Kyung-Hee Oriental Hospital)
Lee, Jin-Moo (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University)
Lee, Chang-Hoon (KangNam Kyung-Hee Oriental Hospital)
Cho, Jung-Hoon (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University)
Jang, Jun-Bock (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University)
Lee, Khung-Sub (KangNam Kyung-Hee Oriental Hospital)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.23, no.4, 2010 , pp. 155-163 More about this Journal
Abstract
Purpose: The aim of the study was to compare the characteristics of the autonomic innervation of the heart in polycystic ovary syndrome(PCOS) patients with regulary cycling controls. Methods: We studied 21 patients visiting $\bigcirc\bigcirc$hospital from 25th June 2009 to 25th June 2010. The subjects were categorized in two groups, 11 PCOS patients and 10 healthy regularly cycling controls. We studied the difference of Heart rate variability (HRV) between two groups by Independent samples T-test using SPSS for windows(version 17.0). Results: The Standard deviation of all normal R-R intervals (SDNN), The spuare root of the sum of the spuare of difference between adjacent normal R-R intervals (RMS-SD) of PCOS group was non-significantly lower than non-PCOS group. High frequency power (HF) and Normalized high frequency power (HF norm) of PCOS group was significantly higher than non-PCOS group. Normalized low frequency power (LF norm) of PCOS was signficantly lower than non-PCOS group. The results means increased sympathetic and decreased vagal modulation. Total power (TP), Very low frequency power (VLF) of PCOS group was non-significantly lower than non-PCOS group. Low frequency power (LF), LF/HF ratio of PCOS group was non-significantly higher than non-PCOS group. Conclusion: The results suggest that PCOS can be related to decreased activity of parasympathetic nervous system.
Keywords
Polycystic ovary syndrome; Heart rate variability; Autonomic nervous system;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Boulman N et al . Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J CLin Endothelial Metab. 2004;89:2160-5.   DOI   ScienceOn
2 張鳳嬋, 薛耀. 中醫藥治療多囊性卵巢綜合症方法初探. 新中醫. 1996;1:14-6.
3 Huikuri et al. Sex related difference in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94:122-5.   DOI   ScienceOn
4 Holly R. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure. Circulation. 1997;96:1835-42.   DOI   ScienceOn
5 Paradisi G et al. Polycystic ovarysyndrome in associated with endothelial dysfunction. Circulation. 2001;103:1410-5.   DOI   ScienceOn
6 박휘라 등. 한국인 다낭난소증후군 환자의 임상특징. 대한내과학회지. 2007; 73(2):169-74.
7 Prelevic GM et al. Cardiac flow velocity in women with polycystic ovary syndrome. Clin Endocrinol. 1995; 43:677-81.   DOI
8 Yarali H et al. Diastolic dysfunction and increased serum homocystein concentrations may contrubute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76:511-6.   DOI   ScienceOn
9 Yildiz BO et al. Global fibrinolytic capacity in decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab. 2002; 87:3871-5.   DOI   ScienceOn
10 Kleiger RE, Stin PK, Bigger JT. Heart rate variablility:Measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10;88-101.   DOI   ScienceOn
11 Lergo RS. Change in glucose intlerance over time in woman with polysystic syndorome: a controlled study. J Clin Endocrinol Metab. 2005;90:3236-42.   DOI   ScienceOn
12 Christian RC et al. Precalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88: 2562-8.   DOI   ScienceOn
13 Lakhani K et al. Intima-medial thickness of elastic and musculra arteries of young women with polycystic ovaries. Atherosclerosis. 2004;175:353-9.   DOI   ScienceOn
14 JE Nestler. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Sem Reprod Endocrinol. 1997;15:111-22.   DOI   ScienceOn
15 조성연 등. 내관 애구가 정신적 스트레스를 가한 성인의 심박변이도에 미치는 영향. 대한침구학회지. 2010; 27(4):51-8.   과학기술학회마을
16 陳貴延, 楊思樹. 實用中西醫結合診斷治療學, 北京中國醫藥科指出版社. 1991: 1004-9.
17 Task Force of European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement physiologic interpretation and clinical use. Circulation. 1996; 93:1043-65.   DOI   ScienceOn
18 Fei L et al. Short and long term assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J cardiol. 1996;77:681-4.   DOI   ScienceOn
19 Kelly CJ et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:742-6.   DOI   ScienceOn
20 성연아. 다낭난소증후군과 인슐린저항성. KOREAN DIABETES. 2008; 32:1-6.   DOI   ScienceOn
21 Aylin Yildirir et al. Heart rate variability in young women with polycystic ovary syndrome. Annals of Noninvasive Electrocardiology. 2006;11(4):306-12.   DOI   ScienceOn
22 Wijeyaratne CN et al. Clinical manifestarions and insulin resistance in polycystic ovary syndrome among asians and caucasians: Is there a difference? Clin Endocrinol. 2002;57:343-50.   DOI   ScienceOn
23 변은경 등. 서울지역 여자대학생에서 다낭성난소증후군의 유병률. 대한내분비학회지. 2005;20(6):120-6.
24 이용제 등. 대사증후군과 심박도의 변이와의 관계. 가정의학회지. 2002; 23(12):1432-9.
25 Evrengul H et al. The relationship between heart rate recovery and heart rate variabiliry in coronary artery disease. Electrocardiol. 2006;11(2): 154-62.
26 오상훈, 황민철, 임재중. HRV에 의한 시각감성의 구분에 대한 연구. 대한인간공학회. 1997;2:473-6.
27 Legro RS. Polycystic ovary syndrome: the new millenium. Mol Cell Endocrinol. 2002;186:882-92.
28 O'Meara NM et al . Defects in $\beta$-cell function in functional ovarian hyperandrogenism. J Clin Endorinol Metab. 1993;76:1241-7.   DOI   ScienceOn
29 Carmina E et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119:356. e1-e6.   DOI
30 Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiacactheterization. Ann Interm Med. 1997;126:32-5.   DOI   ScienceOn
31 Azziz R et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome. J Clin Endothelial Metab. 2001;86:1626-32.   DOI   ScienceOn
32 민응기. 다낭성 난소 증후군. Korean journal of Obstetrics and Gynecology. 2008;51(8):805-19.
33 The Rotterdam ESHRE/ASRM-sponsored PCOS consesus workshop group. Revised 2003 consensus on diagnostic criteria and long health risks related to polycystic ovary syndrome. Hum Reprod. 2004; 19:41-7.   DOI   ScienceOn
34 Legro RS, Kenselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111:607-13.   DOI   ScienceOn